Psychological disorders have been one of the major diseases affecting people’s health, one third of the patients attending general hospitals will suffer from psychological disorders, often unrecognized and unrecognized, psychological disorders are mostly of mild to moderate degree, and when together with physical diseases, it is easy to cause underdiagnosis and misdiagnosis, treatment of psychological disorders in cardiovascular medicine should deserve full attention, a harmful concept is both to recognize that the patient has A harmful concept is to recognize that patients have psychological disorders without considering them as diseases, but only psychological problems, which will not cause much damage to patients; and to think that these so-called psychological problems can get better on their own without treatment; or to think that once patients have organic diseases, it is normal for them to have depression or anxiety reactions, and their anxiety and depression will be eliminated naturally as long as the primary diseases are treated. Severe psychological disorders can have depressive and anxiety disorders, suicidal tendencies, etc., and must be treated by psychiatry. The goal of psychological disorder treatment is to reduce or eliminate the signs and symptoms caused by psychological disorders, improve the prognosis of patients’ physical diseases, improve patients’ quality of life, restore patients’ social functions, and reduce the risk of patients’ relapse or recurrence of psychological disorders. Medications Effective means to improve the symptoms of psychological disorders and control acute attacks, drugs include: a. Anti-anxiety tension and sedative-hypnotic drugs: benzodiazepines are the main drugs, small doses play anti-anxiety tension, larger doses play a sedative-hypnotic effect. Anti-anxiety and tension commonly used include: eszopiclone (Scholastin), 1-2 mg/dose, 2-3 times a day orally; alprazolam (Jiajing Valium), 0.2-0.8 mg/dose, 2-3 times a day orally; diazepam (Valium), 2.5-10 mg/dose, 2-4 times a day orally; non-benzodiazepine anxiolytics, buspirone, 5-10 mg/dose, 3 times a day orally Phenobarbital (luminal), 15~30 mg/dose, 2~3 times a day orally. Sedation and hypnosis commonly used include: triazolam (Hailsham), 0.25-0.5 mg, estradiol, 1-2 mg, taken orally at bedtime; clonidine (clonidine), 1-2 mg, taken orally at bedtime; midazolam (quick sleep), 7.5-15 mg, taken orally at bedtime; zopiclone (Yimengzhi), 7.5 mg, taken orally at bedtime. Second, antidepressants: according to the characteristics of the patient’s symptoms, individualized and rational use of drugs; dose gradually increase, using the minimum effective dose, so as to minimize adverse reactions and improve compliance; small dose is not effective, according to adverse reactions and tolerance, to increase to the full amount (the upper limit of effective drugs) and with a long enough course of treatment (> 4 ~ 6 weeks); if not effective, consider changing drugs. The combination of two or more antidepressants is not advocated for single-agent, full-dose, full-course treatment. The goal of acute treatment is to control the symptoms and achieve clinical recovery as much as possible, and medication usually starts to work in 1~2 weeks, and is not effective in 6~8 weeks. After the acute treatment, the patient’s symptoms have been basically relieved, maintain a higher dose of medication, consolidate the treatment for a period of time, supplemented by the corresponding psychotherapy, generally consolidate the treatment for 4-8 months. After the acute phase and the consolidation phase, the symptoms are controlled, the drug dosage can be started to be reduced, and the first episode is maintained for 6-8 months, and the second episode is maintained for 2-3 years, and more than 2 episodes need long-term treatment. Traditional antidepressant tricyclics: doxepin, 12.5 mg/dose started twice daily, gradually increased to 50-75 mg daily, with an onset of action of 1 to 2 weeks. 5-hydroxytryptamine reuptake inhibitors: fluoxetine, 20 mg/dose, once daily in the morning; paroxetine, 10-20 mg/dose, once daily in the morning; sertraline, 50 mg/dose, once daily in the morning. once a day in the morning. 5-Hydroxytryptamine and norepinephrine reuptake inhibitors: venlafaxine (formerly known as vanlafaxine) extended-release capsules of 75 mg or 150 mg once daily. New antidepressants with effects on both NE and 5-HT transmission: mirtazapine, 15-30 mg/dose, taken orally at bedtime each night. Combination: Dextran (a combination of a low-dose antipsychotic trifloxystrobin and a low-dose tricyclic antidepressant tetramethylpropion), 2 tablets per day, one in the morning or one in the morning and one at noon. Psychotherapy The treatment of psychological disorders, in addition to medication, should be combined with psychotherapy to help improve the remission rate, consolidate the treatment effect and reduce relapse. The methods used include: 1) understanding and sympathy, 2) inquiry and understanding, 3) comfort and reassurance, and 4) answering and solving problems.